Skip to main content

Neural EGFL-like 1, a craniosynostosis-related osteochondrogenic molecule, strikingly associates with neurodevelopmental pathologies

Abstract

Various craniofacial syndromes cause skeletal malformations and are accompanied by neurological abnormalities at different levels, leading to tremendous biomedical, financial, social, and psychological burdens. Accumulating evidence highlights the importance of identifying and characterizing the genetic basis that synchronously modulates musculoskeletal and neurobehavioral development and function. Particularly, previous studies from different groups have suggested that neural EGFL-like-1 (Nell-1), a well-established osteochondrogenic inducer whose biopotency was initially identified in the craniofacial tissues, may also play a vital role in the central nervous system, particularly regarding neurological disorder pathologies. To provide first-hand behavior evidence if Nell-1 also has a role in central nervous system abnormalities, we compared the Nell-1-haploinsufficient (Nell-1+/6R) mice with their wild-type counterparts regarding their repetitive, social communication, anxiety-related, locomotor, sensory processing-related, motor coordination, and Pavlovian learning and memory behaviors, as well as their hippocampus transcriptional profile. Interestingly, Nell-1+/6R mice demonstrated core autism spectrum disorder-like deficits, which could be corrected by Risperidone, an FDA-approved anti-autism, anti-bipolar medicine. Besides, transcriptomic analyses identified 269 differential expressed genes, as well as significantly shifted alternative splicing of ubiquitin B pseudogene Gm1821, in the Nell-1+/6R mouse hippocampus, which confirmed that Nell-1 plays a role in neurodevelopment. Therefore, the current study verifies that Nell-1 regulates neurological development and function for the first time. Moreover, this study opens new avenues for understanding and treating craniofacial patients suffering from skeletal deformities and behavior, memory, and cognition difficulties by uncovering a novel bone-brain-crosstalk network. Furthermore, the transcriptomic analysis provides the first insight into deciphering the mechanism of Nell-1 in neurodevelopment.


Dear editor


Craniofacial disorders manifest over 700 musculoskeletal malformations, such as craniosynostosis, with significant morbidity and mortality. Besides, survivors suffer from physical disfigurement, speech and hearing difficulties, developmental delays, and intellectual disabilities that reduce the overall quality of life. Taking isolated single suture craniosynostosis (SSC) as an example, 45% of patients display one or more speech, cognitive, and behavioral abnormal outcomes or a documented learning disability, special education placement, or identified behavioral problem. Unfortunately, existing treatments are often suboptimal because many craniofacial disorders have no clear pathoetiology to base treatments on. Since numerous craniofacial disorders co-display skeletal and neurodevelopment abnormalities in a “syndromic” fashion, a causal bone-brain relationship whereby skull deformations (e.g., craniosynostosis) that alter intracranial pressures lead to developmental central nervous system (CNS) abnormalities (e.g., neurocognitive impairment) was hypothesized. However, this paradigm is seriously challenged. First, the morphological correlations between the brain and skull are different, and the brain’s developmental trajectory is not in sync with the skull’s. In addition, the presence and significance of anatomical abnormalities in neurocognitive impairment [e.g., autism spectrum disorder (ASD)] is substantial controversy. Moreover, for craniosynostosis associated with neurodevelopmental aberration, such as isolated SSC, no consistent association between neurodevelopmental status and intracranial pressure was observed. Furthermore, abnormal CNS neurodevelopment can occur even after cranial vault reconstruction and restoration of normal intracranial pressures. Nevertheless, until identifying the genes capable of regulating both bone and brain development and understanding their function, the critical knowledge of the craniofacial disorder disease process and how to best treat these patients are largely lacking.

The neural EGFL-like 1 (Nell-1) gene was initially cloned from a human fetal brain cDNA library. Since the in vivo overexpression of Nell-1 was associated with human craniosynostosis and cleidocranial dysostosis (CCD)-like skeletal abnormalities were noticed in neonatal mice with Nell-1-homodeficiency, Nell-1’s osteoinductive and chondrogenic potency has been endorsed in multiple animal models in the last two decades [1]. Some CCD patients exhibit cognitive disorders in adulthood, which suggests Nell-1 may also have neurodevelopmental roles; however, its function in the neural system has yet to be well investigated [1]. Beyond genome-wide association studies (GWAS) that revealed single-nucleotide polymorphism (SNP) of Nell-1 frequently associated with a diversity of neural disorders (Additional file 1: Table S1), the only clue correlated Nell-1 with neurodevelopment is that extremely overexpressing Nell-1 causes massive neural cell apoptosis in developing mouse brain accompanied by acrania-like cranioskeletal deformities [1]. Noticeably, in our recent search for Nell-1’s receptor for osteogenesis, we identified contactin-associated protein-like 4 (Cntnap4) as a specific cell surface receptor for Nell-1 to execute its osteoinductive activity [2]. Cntnap4 is a transmembrane neurexin superfamily member essential for neurodevelopment, neurocognition, and neuropsychiatric disorders [3]. Global Cntnap4-knockout (KO) mice exhibit repetitive, ASD-like behaviors, which could be partially corrected by pharmacological dampening of dopaminergic signaling or augmentation of GABAergic signaling [3]. Zhang et al. also showed that Cntnap4-KO mice suffer from movement deficits [4]. Strikingly, our previous studies demonstrated direct Nell-1 and Cntnap4 binding in the human hippocampus [2], confirming the colocalization of these two molecules in the CNS.

To determine if Nell-1 also has a vigorous CNS role, we used Nell-1-haploinsufficient (Nell-1+/6R) mice, a well-established loss-of-function model [1], in the current study, as homozygous Nell-1-deficient mice die at birth. Restricted and persistent repetitive behaviors and impaired social communication are the two core behavioral characteristics of ASD [5]. For instance, over-grooming and excessive marble-burying are the two typical repetitive phenotypes in mice [5]. Echoing the previous studies that have revealed no significant bone malformations in Nell-1+/6R mice during the development period from newborn to 6-month-old [6], microcomputed tomography (micro-CT) analyses revealed no significant deformity in the calvarial bone of 3-month-old Nell-1+/6R mice (Additional file 2: Fig. S1). Surprisingly, 64% of the tested 3-month-old Nell-1+/6R mice experienced hair loss due to overgrooming repetitive behavior (Fig. 1A). In contrast, none of the wildtype (WT) littermates experienced hair loss (Fig. 1A). Mild hair loss cases mostly occurred in whiskers, perinasal, and periorbital areas of Nell-1+/6R mice (Fig. 1B), moderate cases exhibited large areas of facial hair loss (Fig. 1C), and in severe cases, full-body hair loss (Fig. 1D). The marble-burying test also confirmed repetitive behavior of Nell-1+/6R mice, who buried significantly more marbles than WT littermates (Fig. 1E, and Additional file 3: Video S1). Meanwhile, Nell-1+/6R mice did not display any significant differences from the WT animals in the open field arena test (Additional file 4, Fig. S2) and elevated plus-maze test (Additional file 5: Fig. S3)—the two routinely used methodologies for studying anxiety-related behaviors in mice. At the same time, the former also measures the animal’s locomotor activities [3, 4], suggesting that neither anxiety changes nor deficits in locomotion likely cause the observed repetitive behaviors.

Fig. 1
figure 1

Three-month-old Nell-1+/6R mice presented abnormal behavioral patterns. A The grooming scores were assigned to 50 three-month-old Nell-1+/6R mice (25 females and 25 males) with their fifty WT littermates (25 females and 25 males). No statistical significance was detected between genders of the Nell-1+/6R mice. B Typical appearance of facial hair and whisker loss in the areas around the nose and eyes (for which a score “2” was assigned in panel A ) due to repetitive overgrooming behavior seen in the majority of Nell-1+/6R mice. WT mouse without overgrooming issue (for which a score “0” was assigned in panel A ) was also shown for comparison. g.s. = grooming score. C A three-month-old Nell-1+/6R mouse represented a large area of facial hair loss due to overgrooming (for which a score “3” was assigned in panel A ). D A three-month-old Nell-1+/6R mouse represented full body hair loss due to overgrooming (for which a score “4” was assigned in panel A). E Both male and female Nell-1+/6R  mice represented an increased number of buried marbles comparing to their WT littermates during a 10-minute marble-burying test. Data are presented as a median ± 95% confidence interval, n  = 15 for each group. F Nell-1+/6R  mice represented social behavior abnormalities in the three-chamber social interaction test. The time interacting with either an unfamiliar WT mouse (mouse cup) or an inanimate object (empty cup) in 10 min was shown in the figure in the format of the percentage of total testing time. Data are presented as median ± 95% confidence interval; n  = 12 (female) or 16 (male) for each genotype, respectively. Mann-Whitney U test was used for statistical analysis. N.S. none statistically significant. *: P  < 0.05; ***: P  < 0.005 

Noticeably, although Nell-1+/6R mice have normal performance in a non-social setting (open field arena test [5]) (Additional file 4: Fig. S2), in a social setting (three-chamber social interaction test [5]), Nell-1+/6R mice did not prefer a companion over the empty space when WT mice engaged more with other mice (Fig. 1F). As sensory processing is particularly important for social interactions [3], we performed pre-pulse inhibition (PPI) of the auditory startle reflex and found Nell-1+/6R mice had normal startle response and PPI indexes (Additional file 6: Fig. S4). In addition, the rotarod test was used to examine the animal’s motor coordination [4] and detected no significantly different performance between Nell-1+/6R and WT mice (Additional file 7: Fig. S5). Thus, the social-communicative impairment of Nell-1+/6R mice does not appear to be stemmed from the defective ability to process sensory information or motor dysfunctions.

To the best of our knowledge, this is the first demonstration that Nell-1+/6R mice, which exhibit a high risk of a broad spectrum of abnormal skeletal development and disease such as osteoporosis and arthritis (particularly at their senescent stage, e.g., 18-months old) [1, 6, 7], also start displaying neuropsychiatric abnormalities that strikingly represent ASD in humans at their young adult stage (e.g., 3-months old). Besides, as Nell-1+/6R mice acted similarly to their WT counterparts in the fear conditioning test (Additional file 8: Fig. S6), Nell-1+/6R mice may model an ASD subpopulation without Pavlovian learning and memory disability.

Previous studies have associated the dopaminergic pathway with ASD; thus, we next tested whether Risperidone, an FDA-approved anti-autism, anti-bipolar dopamine antagonist medicine, can reduce Nell-1+/6R mice’s ASD-like behaviors. Since female mice exhibited more obvious behavioral irregularities than their male counterparts (Fig. 1A, E, and F), this initial proof-of-concept study focused on female Nell-1+/6R mice. After 7-days of Risperidone treatment, the female Nell-1+/6R mice reduced their numbers of marbles buried to the same level as their WT littermates (Fig. 2A). Risperidone also normalized the social interaction behavior of Nell-1+/6R mice (Fig. 2B). The ability of Risperidone to significantly “cure” anomalous repetitive behaviors and impacted social interactions of female Nell-1+/6R mice provide strong initial evidence for Nell-1’s vital role in neurological disorders and normal neurological function.

Fig. 2
figure 2

Anti-autism medication rescued Nell-1+/6R mice from autism spectrum disorder-like behaviors. A Marble burying test: three-month-old Nell-1+/6R  mice and their WT littermates with or without intraperitoneal injections were tested. Data are presented as median 95% ± confidence interval; n  = 15 for each group. B Three-chamber social interaction test: percentage of total test time interaction with either an unfamiliar WT mouse (mouse cup) or an inanimate object (empty cup). Three-month-old Nell-1+/6R  mice and their WT littermates were tested with or without intraperitoneal injections. Data are presented as median ± 95% confidence interval, n  = 12 for each group. Mann-Whitney U test was used for statistical analysis. N.S .: none statistically significant. ***: P  < 0.005

Since hippocampal pyramidal cells and interneurons may be critical for regulating excitatory (e.g., dopaminergic) and inhibitory (e.g., GABAergic) brain neurotransmitters to prevent neuropathology, hippocampus tissues of both Nell-1+/6R and WT mice were then collected for transcriptomic analyses to gain more insight into Nell-1’s function in the CNS. The initial global transcriptomic analyses identified 269 differential expressed genes (DEGs) in the Nell-1+/6R mouse hippocampus compared to their WT counterparts (Fig. 3A, and Additional file 9: Table S2). Noticeably, among the top 10 downregulated DEGs (Additional file 9: Table S2), several encode functional proteins in the nervous system. For example, acetylserotonin O-methyltransferase (encoded by Asmt) is the key rate-limiting enzyme of melatonin synthesis that has been reportedly associated with ASD [8], while Asmt-KO induced depression-like behaviors in mice [9]. In addition, reduced serum level of tryptase beta 2 (encoded by Tpsb2) is associated with worse cognitive performance in Alzheimer’s disease [10]. Meanwhile, lysyl oxidase (encoded by Lox) is an enzyme involved in the remodeling of the extracellular matrix whose expression is increased in Alzheimer’s disease [11] and is negatively associated with the prognosis of gliomas [12]. Besides, wingless-type MMTV integration site family, member 6 (encoded by Wnt6) is a protein expressed in the ectoderm which induces neural crest production during craniofacial development [13] while restoring Wnt6 signaling ameliorates the locomotor and social behavioral deficits in a mouse model of Rett syndrome [14]. Moreover, NK6 homeobox 1 (encoded by Nkx6-1) is exclusively expressed in astrocytes in the brainstem, regulates the astrocyte progenitor specification, migration, and maturation [15], and associates with the promoters of several brainstem-specific target genes [16]. On the other hand, among the top 10 upregulated DEGs (Additional file 9: Table S2), Gm15577 specifically expresses in mice cerebellum in a developmentally regulated manner and modulates the expression of Negr1, a gene that has a distinct expression pattern between normal and medulloblastoma patients [17]. Additionally, Slamf1 (encoding the signaling lymphocytic activation molecule family member 1) has been identified as a hub gene associated with molecular subtypes and immune regulation of ischaemic stroke [18]. Meanwhile, small nuclear ribonucleoprotein N (encoded by Snrpn) is highly expressed in all regions of the brain [19, 20], and its mutant has been demonstrated to be associated with Prader-Willi-Like Syndrome [19, 21, 22]. Remarkably, overexpression of Snrpn in mice shortened the length of neurites, resulted in a significant increase in spine dentistry at the distal ends of dendrites, and delayed radial migration in the cerebral cortex, which were assumed to contribute to defects in the potentiation of excitatory synaptic transmission [23], which is associated with intellectual disabilities and ASDs [24]. In addition, D-amino acid oxidase (enclosed by Dao) has been identified as a biomarker for mild cognitive impairment [25], whose inhibition has the potential to be a new therapeutic approach for the treatment of schizophrenia [26]. Furthermore, functional enrichment of the downregulated DEGs against a human gene database recognized ‘SLC-mediated transmembrane transport (the main path for neural transmitter transmission) (Fig. 3B, and Additional file 10: Table S3, Additional file 11: Table S4). At the same time, ‘Prader-Willi and Angelman syndrome,’ a genetic disorder with both musculoskeletal and neuropsychiatric abnormalities, is the top event enriched from the upregulated DEGs (Fig. 3C, and Additional file 12: Table S5, Additional file 13: Table S6).

Fig. 3
figure 3

Global transcriptomic analyses revealed the differences between Nell-1+/6R mouse hippocampus and their WT counterparts. A The heatmap visualizes the Nell-1-responsive differential expressed genes (DEGs) in the mouse hippocampus. N  = 6 (3 males [labeled as blue at the bottom] and 3 females [labeled as pink at the bottom]) for each genotype. B The top 20 of the downregulated DEGs enriched pathways with a P-value less than 0.01. C The upregulated DEGs enriched pathways with a P-value less than 0.01. D Alternative splicing (AS) analysis results with a P-value less than 0.05. The alternative splicing event with a false discovery rate of less than 0.05 is highlighted in red

It is worth noting that the majority of the genes have been found to exhibit alternatively spliced isoforms, which significantly increase the diversity of the transcriptome and markedly modulate their functions [27, 28]. Thus, we also explored the influence of Nell-1-haploinsufficient on mouse hippocampus gene alternative splicing (Additional file 14, Fig. S7) and identified ten genes with significant (P < 0.05, |ΔPSI| > 0.2) alternative splicing events, most of which have known functions in bipolar, epilepsy, autism, and craniofacial syndromes (Additional file 15: Table S7). The transcriptomic analyses support Nell-1 as an essential regulator of both skeletal development and neurodevelopment. Interestingly, we only detected Gm1821, a ubiquitin B (UBB) pseudogene with yet unknown functions, displaying alternative splicing events with a false detection rate (FDR) less than 0.05 (Fig. 3D).

Collectively, by demonstrating the ASD-like behaviors, the capability of anti-autism medication for ‘cure,’ and differential transcriptional profile in the hippocampus of Nell-1-haploinsufficient mice when compared to the WT littermates, we provided first-hand evidence that Nell-1 has vital neurodevelopment roles, particularly in neuropsychiatric disorders in the current study. Furthermore, given our accumulative studies validating the provoke role of Nell-1 in bone and cartilage development and regeneration [1] and the current research demonstrating the functional neuropsychiatric role of Nell-1, we believe that a single molecule, Nell-1, exerts significant roles in both musculoskeletal and neural system development and function. Therefore, our studies may qualify Nell-1 as one essential component of the entire bone-brain crosstalk network [29], while the underlying mechanisms remain to be systematically investigated. Recently, we identified Nell-1 as a novel ligand for Cntnap4 and demonstrated the importance of Cntnap4 for Nell-1-medicated osteogenesis [2]. Particularly, targeted inactivation of either Nell-1 or Cntnap4 in cranial neural crest cells led to remarkably similar defects in the calvarial bones [2]. As a presynaptic molecule, Cntnap4 also modulates neural progenitor cells’ proliferation and neuronal differentiation [30] and regulates dopaminergic and GABAergic synaptic transmission [3]. Thus, global Cntnap4-KO led to core ASD-like deficits in mice [3]. Interestingly, Nell-1+/6R mice also exhibited repetitive, ASD-like behaviors, which can be corrected by pharmacological dampening of dopaminergic signaling. Meanwhile, both Nell-1+/6R mice and Cntnap4-KO mice acted normally in the anxiety tests. Considering the colocalization of Nell-1 and Cntnap4 in hippocampal cells [2], the Nell-1/Cntnap4 functional axis may provide a novel signaling framework for both neural tissue and craniofacial neuro-skeletal interface investigation during development and growth in both health and pathogenic scenarios [29]. No doubt, the molecular events after Nell-1/Cntnap4 binding in the hippocampus [2] remain to be elucidated.

On the other hand, despite many similarities Nell-1+/6R and Cntnap4-KO mice share, their behaviors are not identical. For instance, unlike Cntnap4-KO mice [3, 4], Nell-1+/6R mice had normal startle response and PPI activity. Moreover, no significant difference was found in the rotarod performance (assessing dopaminergic synapse-responsive motor learning function) or fear learning in trace and delay conditioning (representing the structural and functional plasticity of GABAergic synapses) between Nell-1+/6R and WT mice. One possibility is Nell-1+/6R mice are only a Nell-1-haploinsufficient model, and one copy of the Nell-1 gene is sufficient enough to maintain the normal sensory processing and motor coordination function, as well as the learning and memory performance, while the function of dopaminergic and GABAergic synapses are both substantially dampened in Cntnap4-KO mice [3, 4]. However, female Nell-1+/6R mice spent slightly less time in the closed arms relative to the open arms compared to WT controls in the elevated plus maze test (Additional file 5: Fig. S3C), which was not noticed in Cntnap4-KO mice [3]. Moreover, agreed with the gene profiling that associated Nell-1 with Alzheimer’s disease, we noticed that older Nell-1+/6R mice exhibited severe seizure episodes spontaneously and frequently (Additional file 16: Video S2, Additional file 17: Video S3, Additional file 18: Video S4), which were not reported among Cntnap4-KO animals either. These distinctly different behavioral phenotypes between Nell-1+/6R and Cntnap4-KO mice strongly suggest an alternative hypothesis that Nell-1’s neural function is neither fully replicated nor entirely reliant on Cntnap4-responsive synaptic transmission. Particularly, the second theory is more aligned with previous observations that, to manifest its diverse biopotencies, Nell-1 may employ additional receptors except for Cntnap4 [2], which warrants further investigation as well.

Besides, as an 810 amino-acid protein with a postulated homopentamer structure [1], Nell-1 is not expected to penetrate the blood-brain barrier. Thus, Nell-1 may simultaneously but independently orchestrate CNS and craniofacial skeletal growth and development. However, ‘Skeletal system development’ was recognized in the functional enrichment of the identified DEGs (Fig. 3B and Additional file 11: Table S4), although only hippocampus tissue was used for transcriptomic profiling. It is possible that some of Nell-1’s downstream effector(s), which need to be identified in the future, can pass the blood-brain barrier and exert the skeletal modulating effects. Therefore, unlike osteocalcin, which can directly cross the blood-brain barrier [31], Nell-1 may represent another subset of proteins involved in the bone-brain-crosstalk network.

Although they often lack known functions, growing numbers of pseudogenes are being found to play important biological roles [32]. Importantly, knowledge concerning pseudogenes has currently substantially increased due to the availability of high-throughput sequencing techniques, which confirms that pseudogenes have a variety of functions at the DNA, RNA, and protein levels for broadly participating in gene regulation to influence the development and progression of certain diseases [33]. Meanwhile, an aberrant form of UBB was associated with multiple neurodevelopmental disorders (e.g., Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Pick’s disease, Down’s syndrome, other tauopathies, and polyglutamine diseases). Importantly, having a suitable concentration of the correct form of UBB is essential for maintaining normal ATP synthesis, reactive oxygen species (ROS) generation, and mitochondria organization and function in neurons and astrocytes [34]. Considering pseudogenes generally regulate their protein-coding cousins [33], recognizing Gm1821 alternative splicing events in Nell-1+/6R mouse hippocampus may be more than coincidental. Rather, it is possible that Nell-1 modulates UBB signaling by controlling Gm1821 splicing in the neurons and astrocytes to regulate neurological development and function [34], which provides important insight into the previously overlooked influence of pseudogene alternative splicing [32, 33].

It is worth noting that, besides neural or skeletal-related biological processes, immune-related biological processes have also been enriched, including ‘leukocyte migration,’ ‘phagosome,’ ‘regulation of defense response,’ and ‘cytokine-mediated signaling’ (Fig. 3B-C, Additional file 11: Table S4, and Additional file 13: Tables S6). Recently, the term ‘neuro-immuno-skeletal system’ has raised more attention as patients with various syndromes display deficiencies in all these three systems [35, 36]. Thus, the involvement of Nell-1 in the crosstalk among all three systems is also an area to be further explored.

In summary, the current preliminary study on Nell-1’s dual roles in musculoskeletal and neural systems may open new avenues for understanding the pathoetiology of craniofacial disorders and developing more effective, targeted therapeutics. No doubt, much more studies are needed to fully understand and confirm Nell-1’s role in neuropsychiatry, as well as compare the biopotency of Nell-1 and Cntnap4, including but not limited to the use of conditional-KO animal models, viral or other vector-medicated Nell-1 and/or Cntnap4 restoration. However, we hope the current investigation initiates a worldwide collaboration on potential neuropharmaceutical applications of Nell-1—a considerable safe agent currently under a clinical trial for degenerative disc disease and spondylolisthesis (ClinicalTrials.gov Identifier: NCT03810573).

Availability of data and materials

The datasets in this study are available from the corresponding authors upon reasonable request. The RNA-Seq data were submitted to the NIH Gene Expression Omnibus (GEO GSE180856).

Abbreviations

ASD:

Autism spectrum disorder

CCD:

Cleidocranial dysostosis

CNS:

Central nervous system

Cntnap4:

Contactin-associated protein-like 4

DEGs:

Differential expressed genes

FDR:

False detection rate

GWAS:

Genome-wide association studies

KO:

Knockout

Micro-CT:

Microcomputed tomography

Nell-1:

Neural EGFL-like-1

PPI:

Pre-pulse inhibition

ROS:

Reactive oxygen species

SNP:

Single-nucleotide polymorphism

SSC:

Single suture craniosynostosis

UBB:

Ubiquitin B

WT:

Wild-type

References

  1. Li C, Zhang X, Zheng Z, Nguyen A, Ting K, Soo C. Nell-1 is a Key functional modulator in osteochondrogenesis and beyond. J Dent Res. 2019;98(13):1458–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Li C, Zheng Z, Ha P, Chen X, Jiang W, Sun S, Chen F, Asatrian G, Berthiaume EA, Kim JK, et al. Neurexin superfamily cell membrane receptor contactin-associated protein like-4 (Cntnap4) is involved in neural EGFL-Like 1 (Nell-1)-responsive osteogenesis. J Bone Miner Res. 2018;33(10):1813–25.

    Article  CAS  PubMed  Google Scholar 

  3. Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Heron D, Salomon D, Glessner J, Restituito S, et al. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature. 2014;511(7508):236–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Zhang W, Zhou M, Lu W, Gong J, Gao F, Li Y, Xu X, Lin Y, Zhang X, Ding L, et al. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics. 2020;10(7):3000–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Arakawa H. Implication of the social function of excessive self-grooming behavior in BTBR T(+)ltpr3(tf)/J mice as an idiopathic model of autism. Physiol Behav. 2021;237: 113432.

    Article  CAS  PubMed  Google Scholar 

  6. James AW, Shen J, Zhang X, Asatrian G, Goyal R, Kwak JH, Jiang L, Bengs B, Culiat CT, Turner AS, et al. NELL-1 in the treatment of osteoporotic bone loss. Nat Commun. 2015;6:7362.

    Article  CAS  PubMed  Google Scholar 

  7. Li C, Zheng Z, Ha P, Jiang W, Berthiaume EA, Lee S, Mills Z, Pan H, Chen EC, Jiang J, et al. Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug. Biomaterials. 2020;226: 119541.

    Article  CAS  PubMed  Google Scholar 

  8. Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsater H, Rastam M, Stahlberg O, Gillberg IC, Delorme R, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13(1):90–8.

    Article  CAS  PubMed  Google Scholar 

  9. Liu W, Huang Z, Xia J, Cui Z, Li L, Qi Z, Liu W. Gene expression profile associated with asmt knockout-induced depression-like behaviors and exercise effects in mouse hypothalamus. Biosci Rep. 2022. https://doi.org/10.1042/BSR20220800.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wijekoon N, Gonawala L, Ratnayake P, Dissanayaka P, Gunarathne I, Amaratunga D, Liyanage R, Senanayaka S, Wijesekara S, Gunasekara HH, et al. Integrated genomic, proteomic and cognitive assessment in Duchenne muscular dystrophy suggest astrocyte centric pathology. Heliyon. 2023;9(8): e18530.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kelly L, Sharp MM, Thomas I, Brown C, Schrag M, Antunes LV, Solopova E, Martinez-Gonzalez J, Rodriguez C, Carare RO. Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer’s disease. Cereb Circ Cogn Behav. 2023;5:100171.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Xie W, Peng Z, Zhou X, Xia Q, Chen M, Zheng X, Sun H, Zou H, Xu L, Du Z, et al. The expression pattern and clinical significance of Lysyl oxidase family in gliomas. Dokl Biochem Biophys. 2023;510(1):132–43.

    Article  CAS  PubMed  Google Scholar 

  13. Schmidt C, McGonnell I, Allen S, Patel K. The role of wnt signalling in the development of somites and neural crest. Adv Anat Embryol Cell Biol. 2008;195:1–64.

    Article  CAS  PubMed  Google Scholar 

  14. Hsu WL, Ma YL, Liu YC, Tai DJC, Lee EHY. Restoring Wnt6 signaling ameliorates behavioral deficits in MeCP2 T158A mouse model of Rett syndrome. Sci Rep. 2020;10(1):1074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhao X, Chen Y, Zhu Q, Huang H, Teng P, Zheng K, Hu X, Xie B, Zhang Z, Sander M, et al. Control of astrocyte progenitor specification, migration and maturation by Nkx6.1 homeodomain transcription factor. PLoS one. 2014;9(10): e109171.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lozzi B, Huang TW, Sardar D, Huang AY, Deneen B. Regionally distinct astrocytes display unique transcription factor profiles in the adult brain. Front Neurosci. 2020;14: 61.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yue Y, Zhang W, Liu C, Niu Y, Tong W. Long non-coding RNA Gm15577 is involved in mouse cerebellar neurogenesis. Zhonghua Bing Li Xue Za Zhi. 2015;44(7):504–8.

    CAS  PubMed  Google Scholar 

  18. Wei D, Chen X, Xu J, He W. Identification of molecular subtypes of ischaemic Stroke based on immune-related genes and weighted co-expression network analysis. IET Syst Biol. 2023;17(2):58–69.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Glenn CC, Saitoh S, Jong MT, Filbrandt MM, Surti U, Driscoll DJ, Nicholls RD. Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet. 1996;58(2):335–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Schmauss C, Brines M, Lerner M. The gene encoding the small nuclear ribonucleoprotein-associated protein N is expressed at high levels in neurons. J Biol Chem. 1992;267(12):8521–9.

    Article  CAS  PubMed  Google Scholar 

  21. Pellikaan K, van Woerden GM, Kleinendorst L, Rosenberg AGW, Horsthemke B, Grosser C, van Zutven L, van Rossum EFC, van der Lely AJ, Resnick JL, et al. The diagnostic journey of a patient with Prader-Willi-Like Syndrome and a unique homozygous SNURF-SNRPN Variant; bio-molecular analysis and review of the literature. Genes. 2021;12(6):875.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Özçelik T, Leff S, Robinson W, Donlon T, Lalande M, Sanjines E, Schinzel A, Francke U. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the prader–Willi syndrome critical region. Nat Genet. 1992;2(4):265–9.

    Article  PubMed  Google Scholar 

  23. Fradley R, Goetghebeur P, Miller D, Burley R, Almond S, Gruart IMA, Delgado Garcia JM, Zhu B, Howley E, Neill JC, et al. Luvadaxistat: a novel potent and selective D-amino acid oxidase inhibitor improves cognitive and social deficits in Rodent models for schizophrenia. Neurochem Res. 2023;48(10):3027–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Li H, Zhao P, Xu Q, Shan S, Hu C, Qiu Z, Xu X. The autism-related gene SNRPN regulates cortical and spine development via controlling nuclear receptor Nr4a1. Sci Rep. 2016;6(1): 29878.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lane HY, Wang SH, Lin CH. Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline. Psychiatry Res. 2023;326: 115288.

    Article  PubMed  Google Scholar 

  26. O’Donnell P, Dong C, Murthy V, Asgharnejad M, Du X, Summerfelt A, Lu H, Xu L, Wendland JR, Dunayevich E, et al. The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial. Neuropsychopharmacology. 2023;48(7):1052–9.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463(7280):457–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456(7221):470–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012;481(7381):314–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Yin FT, Futagawa T, Li D, Ma YX, Lu MH, Lu L, Li S, Chen Y, Cao YJ, Yang ZZ, et al. Caspr4 Interaction with LNX2 modulates the proliferation and neuronal differentiation of mouse neural progenitor cells. Stem Cells Dev. 2015;24(5):640–52.

    Article  CAS  PubMed  Google Scholar 

  31. Obri A, Khrimian L, Karsenty G, Oury F. Osteocalcin in the brain: from embryonic development to age-related decline in cognition. Nat Rev Endocrinol. 2018;14(3):174–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Cheetham SW, Faulkner GJ, Dinger ME. Overcoming challenges and dogmas to understand the functions of pseudogenes. Nat Rev Genet. 2020;21(3):191–201.

    Article  CAS  PubMed  Google Scholar 

  33. Chen X, Wan L, Wang W, Xi WJ, Yang AG, Wang T. Re-recognition of pseudogenes: from molecular to clinical applications. Theranostics. 2020;10(4):1479–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Banasiak K, Szulc NA, Pokrzywa W. The dose-dependent Pleiotropic effects of the UBB(+ 1) ubiquitin mutant. Front Mol Biosci. 2021;8: 650730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Oud MM, Tuijnenburg P, Hempel M, van Vlies N, Ren Z, Ferdinandusse S, Jansen MH, Santer R, Johannsen J, Bacchelli C, et al. Mutations in EXTL3 cause neuro-immuno-skeletal dysplasia syndrome. Am J Hum Genet. 2017;100(2):281–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Fusaro M, Vincent A, Castelle M, Rosain J, Fournier B, Veiga-da-Cunha M, Kentache T, Serre J, Fallet-Bianco C, Delezoide AL, et al. Two Novel homozygous mutations in phosphoglucomutase 3 leading to severe combined immunodeficiency, skeletal dysplasia, and malformations. J Clin Immunol. 2021;41(5):958–66.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. Cymbeline T. Culiat for providing the Nell-1+/6R mice strain, UCLA Rodent Behavioral Testing Core for assistance with behavioral tests data acquiring and analysis, UCLA Technology Center for Genomics & Bioinformatics for assistance with high throughput sequencing data acquiring and analysis, and Dr. Hsin-Chuan Pan for video production.

Funding

This work was supported by NIH-NIAMS [grants R01AR066782 (for K.T.) and R01AR068835 (for C.S.)], NIH-NIDCR [grant R03DE030400 (for C.L.)], the American Association of Orthodontists Foundation (AAOF) Orthodontic Faculty Development Fellowship Award (for C.L.), University of Pennsylvania School of Dental Medicine Joseph and Josephine Rabinowitz Award for Excellence in Research (for C.L.), the J. Henry O’Hern Jr. Pilot Grant from the Department of Orthodontics, University of Pennsylvania School of Dental Medicine (for C.L.), and the 2023 International Orthodontics Foundation (IOF) Research Grant (for C.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.

Author information

Authors and Affiliations

Authors

Contributions

Study Design and drafting the manuscript: CL and ZZ; study conduct: CL, ZZ, PH, and WJ; data analysis: CL and ZZ; study supervision and final approval of the manuscript: CS, and KT.

Corresponding authors

Correspondence to Chia Soo or Kang Ting.

Ethics declarations

Ethics approval and consent to participate

All the experiments on live mice were performed under an institutionally approved protocol provided by the Chancellor’s Animal Research Committee at UCLA (protocol numbers: 2014-041 and 2013-013).

Consent for publication

Not applicable.

Competing interests

C.L., Z.Z., C.S., and K.T. are inventors of Nell-1 related patents. C.S., and K.T. are also founders and/or past board members of Bone Biologics Inc./Bone Biologics Corp., who sublicense Nell-1 patents from the UC Regents, who also hold equity in the company. Bone Biologics Inc./Bone Biologics Corp. did not provide financial support for the current study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Known Nell-1 SNP correlated with neurodevelopmental disorders.

Additional file 2: Fig. S1.

Micro-CT analyses revealed no significant calvarial bone malformations in 3-month-old Nell-1+/6R  mice.

Additional file 3: Video S1.The representative video of a pair of 3-month-old female Nell-1+/6R mouse and the WT littermate in a 10-minute marble-burying test.

Additional file 4: Fig. S2.

The Nell-1+/6R mice did not represent major changes in anxiety levels as indicated by the open field arena (OFA) test. The total travel distance (A) and time spent in periphery versus center in two different central percentage calculations (66% in B, and 50% in C) are presented. No difference was found between Nell-1+/6R mice and their WT littermates for both genders. Data are presented as median ± 95% confidence interval, N= 16 for each group. Mann-Whitney U test was used for statistical analysis. N.S.: none statistically significant.

Additional file 5: Fig. S3.

Female Nell-1+/6R mice but not the males presented impaired anxiety level in the elevated plus maze test. The total travel distance (A), the duration of stretched attend posture (SAP, B), and time spent in open versus closed arms (C) are presented. No difference was found between 3-month-old male Nell-1+/6R mice and their WT littermates. On the other hand, female Nell-1+/6R mice spent slightly less time on the closed arms than their WT counterparts, while no difference was found in other parameters. Data are presented as median ± 95% confidence interval, N= 16 for each group. Mann-Whitney U test was used for statistical analysis. N.S.: none statistically significant. *: P < 0.05.

Additional file 6: Fig. S4.

The Nell-1+/6R mice did not represent major changes in sensorimotor integration as indicated by the pre-pulse inhibition (PPI) test. The mean of the first 6, middle 10, and last 6 startle at 120 dB (A) and the percentage of PPI at 74, 82, 90 dB (B) are presented. No difference was found between Nell-1+/6R mice and their WT littermates for both genders. Data are presented as median ± 95% confidence interval, N = 14 (female) or 16 (male) mice per genotype, respectively. Mann-Whitney U test was used for statistical analysis. N.S.: none statistically significant.

Additional file 7: Fig. S5.

The Nell-1+/6R mice did not represent major changes in motor coordination as indicated by the Rotarod performance test. (A) The length of latency to fall for 3-month-old Nell-1+/6R mice and their WT littermates, as well as (B) the revolutions per minute (rpm) for 3-month-old Nell-1+/6R mice and their WT counterparts are presented. No difference was found between Nell-1+/6R mice and their WT littermates for both genders. Data are presented as median ± interquartile range, N = 16 for each group. Mann-Whitney U test was used for statistical analysis.

Additional file 8: Fig. S6.

The Nell-1+/6R mice did not represent major changes in learning and memory as indicated by the fear conditioning test. The baseline (BL, A), percentage time of freezing behavior during the total testing time of context fear (B), tone (C), and trace (D) for both trace and delay fear conditioning tests of 3-month-old Nell-1+/6R mice and their WT littermates are presented. No difference was found between Nell-1+/6R mice and their WT counterparts for both genders. Data are presented as median ± 95% confidence interval. In the trace conditioning test, N= 16 (female) or 8 (male) for each genotype; in the delay conditioning test, N = 14 (female) or 8 (male) for each genotype, respectively. Mann-Whitney U test was used for statistical analysis. N.S.: none statistically significant.

Additional file 9: Table S2.

The list of differentially expressed genes (DEGs) in the hippocampus from Nell-1+/6R mice and their wild-type littermates.

Additional file 10: Table S3.

The converting results of the input downregulated DEGs in the Metascape.

Additional file 11: Table S4.

The result of pathway and process enrichment analysis with the downregulated DEGs.

Additional file 12: Table S5.

The converting results of the input upregulated DEGs in the Metascape.

Additional file 13: Table S6.

The result of pathway and process enrichment analysis with the upregulated DEGs.

Additional file 14: Fig. S7. 

The demography of alternative splice events detected by CASH.

Additional file 15: Table S7.

The alternative splicing gene list with a P-value less than 0.05.

Additional file 16: Video S2.A 12-month-old female Nell-1+/6R mouse experienced seizures during a daily mouse check.

Additional file 17: Video S3.A cage of four 18-month-old female Nell-1+/6R mice. Two of the mice experienced seizures during a daily mouse check.

Additional file 18: Video S4.A cage of four 18-month-old male Nell-1+/6R mice. Two of the mice experienced seizures during a daily mouse check.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, C., Zheng, Z., Ha, P. et al. Neural EGFL-like 1, a craniosynostosis-related osteochondrogenic molecule, strikingly associates with neurodevelopmental pathologies. Cell Biosci 13, 227 (2023). https://doi.org/10.1186/s13578-023-01174-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13578-023-01174-5

Keywords